Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
102.80
+2.58 (2.57%)
Jan 15, 2026, 4:00 PM EST - Market closed
Encompass Health Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$142.86
Upside
+38.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $141 → $150 | Buy | Maintains | $141 → $150 | +45.91% | Oct 30, 2025 |
| UBS | UBS | Strong Buy Maintains $140 → $150 | Strong Buy | Maintains | $140 → $150 | +45.91% | Oct 2, 2025 |
| Keybanc | Keybanc | Buy Maintains $135 → $140 | Buy | Maintains | $135 → $140 | +36.19% | Sep 16, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $145 → $160 | Strong Buy | Maintains | $145 → $160 | +55.64% | Sep 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $135 → $140 | Strong Buy | Maintains | $135 → $140 | +36.19% | Aug 14, 2025 |
| UBS | UBS | Strong Buy Maintains $130 → $140 | Strong Buy | Maintains | $130 → $140 | +36.19% | Aug 6, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $135 | Buy | Reiterates | $135 | +31.32% | Jun 5, 2025 |
| Keybanc | Keybanc | Buy Maintains $122 → $135 | Buy | Maintains | $122 → $135 | +31.32% | May 27, 2025 |
| UBS | UBS | Strong Buy Maintains $117 → $130 | Strong Buy | Maintains | $117 → $130 | +26.46% | Apr 28, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $110 → $125 | Buy | Maintains | $110 → $125 | +21.60% | Apr 28, 2025 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $116 → $135 | Strong Buy | Reiterates | $116 → $135 | +31.32% | Apr 28, 2025 |
| Keybanc | Keybanc | Buy Maintains $120 → $122 | Buy | Maintains | $120 → $122 | +18.68% | Apr 25, 2025 |
| Barclays | Barclays | Buy Maintains $118 → $129 | Buy | Maintains | $118 → $129 | +25.49% | Apr 25, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $110 | Buy | Reiterates | $110 | +7.00% | Feb 11, 2025 |
| Keybanc | Keybanc | Buy Maintains $117 → $120 | Buy | Maintains | $117 → $120 | +16.73% | Feb 10, 2025 |
| Barclays | Barclays | Buy Maintains $116 → $118 | Buy | Maintains | $116 → $118 | +14.79% | Feb 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.